Evidence map›Paper›PMID 40108630›Full record

ReviewMolecular cancer2025

Extracellular vesicles in cancer´s communication: messages we can read and how to answer.

Alena Semeradtova, Michaela Liegertova, Regina Herma, Magdalena Capkova, Chiara Brignole, Genny Del Zotto

Abstract readReview
In one paragraph

Review in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. SFRP2Molecular carcinogenesis · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Thbs1Journal of advanced research · 2026
    Article
  8. Review
  9. Article
  10. Condensates on the Move: Midbody Remnants as Large, Translation-Competent Extracellular Vesicles.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  11. Article
  12. GLS1 Orchestrates Exosome-Mediated Tumor-Endothelial Communication to Facilitate Angiogenesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alena SemeradtovaInstitute of Photonics and Electronics of the CAS, Chaberská 1014/57, Prague, 182 51, Czech Republic. semeradtova@ufe.cz.ORCID http://orcid.org/0009-0006-9629-2846
Michaela LiegertovaCentre for Nanomaterials and Biotechnology, Faculty of Science, Jan Evangelista Purkyně University in Ústí Nad Labem, Pasteurova 3632/15, Ústí Nad Labem, 40096, Czech Republic.ORCID http://orcid.org/0000-0003-3858-856X
Regina HermaCentre for Nanomaterials and Biotechnology, Faculty of Science, Jan Evangelista Purkyně University in Ústí Nad Labem, Pasteurova 3632/15, Ústí Nad Labem, 40096, Czech Republic.ORCID http://orcid.org/0000-0001-7965-8195
Magdalena CapkovaInstitute of Photonics and Electronics of the CAS, Chaberská 1014/57, Prague, 182 51, Czech Republic.ORCID http://orcid.org/0000-0001-5630-8045
Chiara BrignoleLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Via G. Gaslini 5, 16147, Genoa, Italy. chiarabrignole@gaslini.org.ORCID http://orcid.org/0000-0002-2563-6991
Genny Del ZottoCore Facilities, Department of Research and Diagnostics, IRCCS Istituto Giannina Gaslini, 16147, Genoa, Italy. gennydelzotto@gmail.com.ORCID http://orcid.org/0000-0001-7272-7776

Funding

European Union - Next Generation EU 20-23787XItalian Ministry of Health 5M-2019-23680417MATBIOMED - Materials and Technologies for Bioapplications and Medicine reg. no.: CZ.02.01.01/00/23_021/0008398National Institute for Cancer Research Programme EXCELES LX22NPO5102Research Infrastructure NanoEnviCz LM2018124
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are emerging as critical mediators of intercellular communication in the tumor microenvironment (TME), profoundly influencing cancer progression. These nano-sized vesicles, released by both tumor and stromal cells, carry a diverse cargo of proteins, nucleic acids, and lipids, reflecting the dynamic cellular landscape and mediating intricate interactions between cells. This review provides a comprehensive overview of the biogenesis, composition, and functional roles of EVs in cancer, highlighting their significance in both basic research and clinical applications. We discuss how cancer cells manipulate EV biogenesis pathways to produce vesicles enriched with pro-tumorigenic molecules, explore the specific contributions of EVs to key hallmarks of cancer, such as angiogenesis, metastasis, and immune evasion, emphasizing their role in shaping TME and driving therapeutic resistance. Concurrently, we submit recent knowledge on how the cargo of EVs can serve as a valuable source of biomarkers for minimally invasive liquid biopsies, and its therapeutic potential, particularly as targeted drug delivery vehicles and immunomodulatory agents, showcasing their promise for enhancing the efficacy and safety of cancer treatments. By deciphering the intricate messages carried by EVs, we can gain a deeper understanding of cancer biology and develop more effective strategies for early detection, targeted therapy, and immunotherapy, paving the way for a new era of personalized and precise cancer medicine with the potential to significantly improve patient outcomes.

Indexed as

Cell CommunicationExtracellular VesiclesNeoplasmsAnimalsBiomarkers, TumorHumansTumor MicroenvironmentBiomarkers, TumorBiomarkersCancerExtracellular vesiclesImmune evasionLiquid biopsyMetastasisTargeted therapyTumor microenvironment

Identifiers

PMID40108630
PMCPMC11921637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.